---
schema_version: "secwatch.filing_event.v1"
accession: "0000037785-26-000036"
form_type: "8-K"
ticker: "FMC"
cik: "0000037785"
company_name: "FMC CORP"
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T05:07:21.733191+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# FMC explores strategic options including sale; Q4 net loss $1.72B on impairment

## Summary
- Board authorized exploration of strategic options including a sale to unlock shareholder value.
- Q4 2025 revenue $1.08B (-12% YoY); full year revenue $3.47B (-18%).
- Q4 GAAP net loss $1.72B ($13.74 loss per diluted share) driven by non-cash goodwill impairment.
- FY 2026 revenue guidance $3.60-3.80B; Adjusted EPS $1.63-1.89; free cash flow near zero.
- Plans to pay down $1B debt through asset sales and licensing; new active ingredient sales target $300-400M.

## SEC filing metadata
- accession: 0000037785-26-000036
- form_type: 8-K
- ticker: FMC
- cik: 0000037785
- company_name: FMC CORP
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/37785/000003778526000036/0000037785-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/37785/000003778526000036/fmc-20260204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000037785-26-000036
- JSON: https://secwatch.observer/filing/0000037785-26-000036.json
- Plain text: https://secwatch.observer/filing/0000037785-26-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.